Wealth Enhancement Advisory Services’s Inspire Corporate Bond ETF IBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$268K Sell
11,301
-7,034
-38% -$168K ﹤0.01% 3305
2026
Q1
$439K Sell
18,335
-567,085
-97% -$13.7M ﹤0.01% 2433
2025
Q4
$14.1M Buy
+585,420
New +$14.2M 0.02% 585

Other funds holding IBD

Wealth Enhancement Advisory Services's IBD Position: Q2 2026 in Review

Wealth Enhancement Advisory Services reduced its Inspire Corporate Bond ETF (IBD) stake by 38% in Q2 2026, selling an estimated $168K and leaving 11,301 shares worth $268K. The position accounts for ﹤0.01% of the portfolio, ranked #3305.

Wealth Enhancement Advisory Services first reported a position in IBD in Q4 2025 and has held it in 3 quarters since. The position peaked at $14.1M in Q4 2025. 110 funds tracked by Wall St. Rank hold IBD as of Q2 2026.

  • Wealth Enhancement Advisory Services held 11,301 shares of Inspire Corporate Bond ETF worth $268K as of Q2 2026.
  • Wealth Enhancement Advisory Services sold 7,034 Inspire Corporate Bond ETF shares in Q2 2026, an estimated $168K.
  • Inspire Corporate Bond ETF made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #3305 holding.
  • Wealth Enhancement Advisory Services first reported a position in Inspire Corporate Bond ETF in Q4 2025 and has held it in 3 quarters since.
  • Wealth Enhancement Advisory Services's Inspire Corporate Bond ETF position peaked at $14.1M in Q4 2025.
  • 110 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.